Amneal Pharmaceuticals, Inc 10-Q for FY2020 Q2
Amneal Pharmaceuticals, Inc. (AMRX)
10-Q
2020-08-06
For: 2020-06-30
View Original
Added on
April 06, 2026
About this 10-Q
Amneal Pharmaceuticals, Inc filed this 10-Q on August 6, 2020, covering the quarter ended June 30, 2020 (FY2020 Q2).
Headline figures
Quarter ended June 30, 2020, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $464.66M
- up 14.8% from $404.64M a year earlier
- Net loss
- $12M
- compared with a net loss of $16.9M a year earlier
- Diluted EPS
- -$0.08
- compared with -$0.13 a year earlier